While no specific genetic signature has been identified for SEDC, studies suggest that TP53, PIK3CA, and HRAS mutations may be implicated in adnexal malignancies, similar to SCC [37,40]. The gene discussed is TP53; the disease is spondyloepiphyseal dysplasia congenita.